Preliminary Safety and Potential Effect of 6B11-OCIK Adoptive Cell Therapy Against Platinum-Resistant Recurrent or Refractory Ovarian Cancer

Ovarian cancer is a leading cause of death among gynecological malignancies, and novel therapies are urgently needed. Here we report preliminary findings on the potential safety and efficacy of 6B11-OCIK, an adoptive cell therapy of autologous T cells induced by the humanized anti-idiotypic antibody...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Hongyan, Ma, Ruiqiong, Wang, Shang, Wang, Yu, Li, Yingchun, Tang, Zhijian, Dou, Sha, Wang, Yuanfen, Zhu, Honglan, Ye, Xue, Zhang, Tianyu, Zhang, Yonghua, Li, Shufen, Zhao, Yonghong, Li, Yi, Cui, Heng, Chang, Xiaohong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366315/
https://www.ncbi.nlm.nih.gov/pubmed/34408750
http://dx.doi.org/10.3389/fimmu.2021.707468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366315/
https://www.ncbi.nlm.nih.gov/pubmed/34408750
http://dx.doi.org/10.3389/fimmu.2021.707468

Ejemplares similares